The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Lynn D Bardin1,2
- Peter King3
- Chris G Maher4
- 1 Austin Health, Melbourne, VIC
- 2 SuperSpine, Melbourne, VIC
- 3 King St Medical Centre, Melbourne, VIC
- 4 George Institute for Global Health, Sydney, NSW
Chris Maher holds a fellowship from the National Health and Medical Research Council (NHMRC), and is chief investigator or associate investigator on multiple previous and current research grants from government research agencies in Australia (NHMRC), Brazil (São Paulo Research Foundation) and the Netherlands (Netherlands Organisation for Health Research and Development). He has also received funding from organisations such as Arthritis Australia and government agencies such as WorkCover, and has received supplementary industry funding for two investigator-initiated NHMRC-funded trialsPACE (; cofunded by GlaxoSmithKline); and PRECISE (NCT00076986; Pfizer supplied the study medicine at no cost but provided no other funding).
Summary